Nature | Medicine
Follow
Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency
Analyzing data from the SURMOUNT-1 trial, the authors show that the weight loss effects of tirzepatide treatment are similar in carriers and noncarriers of MC4R pathogenic mutations.
